Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 3Phase NA 2Phase 1 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Venous Thrombosis 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Colorectal Neoplasms 1Cardiovascular Diseases 1

Interventions

Radiosurgery 45Magnetic Resonance Spectroscopy 41Standard of Care 27Radiotherapy 27Exercise 27Brachytherapy 21Early Intervention, Educational 20Surveys and Questionnaires 18Multiparametric Magnetic Resonance Imaging 17Magnetic Resonance Imaging 16Androgen Antagonists 16Blood Specimen Collection 15Interviews as Topic 14Radiotherapy, Intensity-Modulated 13Methods 13Therapeutics 12Psychiatric Rehabilitation 12Educational Status 12Biopsy 12Specimen Handling 10Resistance Training 10Prostatectomy 9Diet Therapy 9Counseling 9gallium 68 PSMA-11 8Radiation 8Proton Therapy 8Practice Guidelines as Topic 8High-Intensity Interval Training 7Electroporation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Prostatic Neoplasms × Atorvastatin × Clear all
NCT03127631 2025-01-31

RADICALPC

McMaster University

Phase NA Recruiting
6,000 enrolled
Genitourinary

Cardiovascular Diseases, Prostatic Neoplasms

NCT01555632 2023-08-14

Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy

University of Nebraska

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡